CHC Healthcare Group (TPE:4164)
33.45
+0.45 (1.36%)
Feb 11, 2026, 1:30 PM CST
CHC Healthcare Group Revenue
CHC Healthcare Group had revenue of 1.10B TWD in the quarter ending September 30, 2025, with 14.14% growth. This brings the company's revenue in the last twelve months to 4.21B, up 4.42% year-over-year. In the year 2024, CHC Healthcare Group had annual revenue of 3.60B, down -7.13%.
Revenue (ttm)
4.21B
Revenue Growth
+4.42%
P/S Ratio
1.55
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.60B | -276.56M | -7.13% |
| Dec 31, 2023 | 3.88B | 902.79M | 30.35% |
| Dec 31, 2022 | 2.97B | 534.79M | 21.92% |
| Dec 31, 2021 | 2.44B | -115.35M | -4.51% |
| Dec 31, 2020 | 2.55B | -395.14M | -13.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Formosa Laboratories | 4.90B |
| Hi-Clearance | 4.19B |
| SCI Pharmtech | 1.39B |
| Orient Pharma | 1.28B |
| Delta Asia International | 711.19M |
| Mycenax Biotech | 649.64M |